ANIDULAFUNGIN Accord subst seche 100 mg 1 pce

7680683570019 CH-68357 J02AX06 08.06.0.

Active substances:

ANIDULAFUNGIN Accord subst seche 100 mg 1 pce
ANIDULAFUNGIN Accord subst seche 100 mg 1 pce
ANIDULAFUNGIN Accord subst seche 100 mg 1 pce
1 / 3
google

Details

Product number
6835701
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: anidulafunginum 100 mg, fructosum 100 mg, mannitolum, polysorbatum 80, acidum (S)-lacticum, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 1.5 mg, pro vitro.

Articles (1)

Anidulafungin Accord 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
28/05/2026
Professional SmPC
Français
28/05/2026
Professional SmPC
Italien
28/05/2026

Detailed composition

Substance Quantity Type Category
anidulafunginum
100.0 MG Substance Wirkstoff (Principe actif)
fructosum
100.0 MG Substance HBESI
mannitolum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
acidum (S)-lacticum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 381.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2022

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
68357
Drug name
Anidulafungin Accord, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
J02AX06
Authorization status
Z
Dispensation category
A
First authorization
18/11/2021
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Packaging details

Description (FR)
ANIDULAFUNGIN Accord subst seche 100 mg 1 pce
Description (DE)
ANIDULAFUNGIN Accord Trockensub 100 mg 1 Stk
Market launch
18/11/2021
Narcotic (BTM)
No

Original drug

Ecalta, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
CHF 442.80
View original
Buy us a coffee Explore the data